Array BioPharma Inc (ARRY)

3.74
0.03 0.80
NASDAQ : Health Care
Prev Close 3.77
Open 3.76
Day Low/High 3.65 / 3.81
52 Wk Low/High 2.38 / 6.56
Volume 916.35K
Avg Volume 1.90M
Exchange NASDAQ
Shares Outstanding 143.44M
Market Cap 553.69M
EPS 0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Array BioPharma (ARRY) Stock: Weak On High Volume Today

Array BioPharma (ARRY) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Array BioPharma (ARRY) as a weak on high relative volume candidate

First Week of December 16th Options Trading For Array BioPharma (ARRY)

First Week of December 16th Options Trading For Array BioPharma (ARRY)

Investors in Array BioPharma Inc. saw new options begin trading this week, for the December 16th expiration.

Loxo Cancer Drug Targets Gene Mutation With Durable Responses in Early Study

Loxo Cancer Drug Targets Gene Mutation With Durable Responses in Early Study

Six patients, all with TRK fusion cancers unresponsive to current therapies, reported tumor shrinkage following treatment with Loxo's drug LOXO-101.

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate

Array BioPharma (ARRY) Is Strong On High Volume Today

Array BioPharma (ARRY) Is Strong On High Volume Today

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate

Commit To Buy Array BioPharma At $2, Earn 25% Using Options

Commit To Buy Array BioPharma At $2, Earn 25% Using Options

Investors eyeing a purchase of Array BioPharma Inc. stock, but tentative about paying the going market price of $3.19/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Short Interest In Array BioPharma Moves 10.3% Lower

Short Interest In Array BioPharma Moves 10.3% Lower

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 2,674,046 share decrease in total short interest for Array BioPharma Inc. , to 23,339,973, a decrease of 10.28% since 12/15/2015.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

QIAGEN Reaches Milestone With Portfolio Of Master Collaboration Agreements For Pharma Companion Diagnostics

QIAGEN Reaches Milestone With Portfolio Of Master Collaboration Agreements For Pharma Companion Diagnostics

Record number of new projects involves start of new master collaboration with Array BioPharma

Array Biopharma (ARRY) Stock Spikes on Successful Drug Study

Array Biopharma (ARRY) Stock Spikes on Successful Drug Study

Array Biopharma (ARRY) stock is skyrocketing in afternoon trading on Wednesday following a successful late-stage study for its skin cancer drug.

Array BioPharma (ARRY) Moving On Heavy Pre-Market Trading

Array BioPharma (ARRY) Moving On Heavy Pre-Market Trading

Trade-Ideas LLC identified Array BioPharma (ARRY) as a pre-market mover with heavy volume candidate

Array BioPharma (ARRY): Today's Weak On High Volume Stock

Array BioPharma (ARRY): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Array BioPharma (ARRY) as a weak on high relative volume candidate

Array BioPharma (ARRY) Strong On High Relative Volume Today

Array BioPharma (ARRY) Strong On High Relative Volume Today

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate

Trade-Ideas: Array BioPharma (ARRY) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Array BioPharma (ARRY) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified Array BioPharma (ARRY) as a weak on high relative volume candidate

Array BioPharma Enters Oversold Territory (ARRY)

Array BioPharma Enters Oversold Territory (ARRY)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of ARRY June 2016 Options Trading

First Week of ARRY June 2016 Options Trading

Investors in Array BioPharma Inc. saw new options begin trading this week, for the June 2016 expiration.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

Array BioPharma Becomes Oversold (ARRY)

Array BioPharma Becomes Oversold (ARRY)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting ARRY Put And Call Options For November 20th

Interesting ARRY Put And Call Options For November 20th

Investors in Array BioPharma Inc. saw new options become available this week, for the November 20th expiration.

Array BioPharma (ARRY) Flagged As Strong On High Volume

Array BioPharma (ARRY) Flagged As Strong On High Volume

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ASPN Downgrades: ARRY, BEN, CF, DISCK, LTS, OAK, OB, QCOM, SCX, SF, SIFI, VECO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

'Mad Money' Lightning Round: I'm No Fan of Groupon

'Mad Money' Lightning Round: I'm No Fan of Groupon

Cramer thinks EOG is terrific, Williams Partners is great but he's moving on from Motorola Solutions.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

This volatile week ended with a whimper and Cramer is already looking to next week's wealth of earnings and economic data.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China

Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide From China

China's problems continue to knock a number of U.S. stocks upside the head, Cramer says.

'Mad Money' Lightning Round: Marriott International Is a Buy

'Mad Money' Lightning Round: Marriott International Is a Buy

Cramer says he can't recommend CenturyLink but likes VeriFone and Blackhawk Network.